New Delhi, May 12 -- Goldline Pharmaceutical IPO Day 1: The initial public offering (IPO) of Goldline Pharmaceutical opened for subscription today, 12 May, and will close on Thursday, 14 May. The SME IPO price band has been set in the range of Rs. Rs.41-43 per share.

The company aims to raise Rs.11.61 crore from this issue, which is entirely a fresh issue of 0.27 crore shares with no offer for sale component.

The basis of allotment for the IPO is likely to be finalised on May 15, 2026. Investors who receive shares are expected to see them credited to their demat accounts by May 18, while applicants who do not receive allotment may get their refunds initiated the same day. The company is tentatively scheduled to debut on the BSE SME plat...